SCHEMBL13009164

SCHEMBL13009164

CC1(C)c2ccccc2-c2ccc(-c3ccccc3-c3c4ccc(N5c6ccccc6Sc6ccccc65)cc4c(-c4ccccc4)c4ccc(N5c6ccccc6Sc6ccccc65)cc34)cc21

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13009400 0.96 HDAC6 (0.31) HDAC6
SCHEMBL13009145 0.96 HDAC6 (0.31) HDAC6
SCHEMBL13008651 0.96 HDAC6 (0.31) HDAC6
SCHEMBL13009351 0.96 HDAC6 (0.32) HDAC6
SCHEMBL13427203 0.95 PDK2 (0.32) HDAC6
SCHEMBL13009188 0.93 PDK2 (0.31)
SCHEMBL13009398 0.93 HDAC6 (0.33) HDAC6
SCHEMBL13427133 0.93 HDAC6 (0.33) HDAC6
SCHEMBL13009013 0.92
SCHEMBL13427209 0.91 PGR (0.31) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A HDAC6 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.